Sulphonamides Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

Global Sulfonamide Market is Segmented by Route of Administration (Oral, Topical, and Other Routes of Administration), Application (Skin Infection, Gastro-Intestinal Tract (GIT) Infection, Urinary Tract Infection (UTI), Respiratory Tract Infection (RTI), and Other Applications), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report offers the value (in USD million) for the above segments.

Sulphonamides Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

Sulphonamides Industry Overview

The sulphonamides market is fragmented and consists of several major players. Companies like AA Pharma Inc., Abbott Laboratories, Akorn Operating Company LLC, GSK PLC, Lexine Technochem Pvt. Ltd, Viatris Inc., Pfizer Inc., Amneal Pharmaceuticals LLC, Teva Pharmaceutical Industries Ltd, and F. Hoffmann-La Roche Ltd hold a substantial share in the market. However, with technological advancements and product innovations, mid-size to smaller companies are increasing their market presence by introducing new products at lesser prices.

Sulphonamides Market Leaders

  1. Pfizer Inc.

  2. AA Pharma Inc.

  3. GSK plc

  4. Viatris Inc

  5. Teva Pharmaceutical Industries Ltd

  6. *Disclaimer: Major Players sorted in no particular order
Sulphonamides Market.png